IP Library Granted Patent US 6,979,668
Granted Patent B2
US 6,979,668 · App. 10/320,045 · Granted Dec 27, 2005

Cleaning compound for and method of cleaning valves and actuators of metered dose dispensers containing pharmaceutical compositions

Assignee: Generex Pharmaceuticals Incorporated
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,979,668
App. No.
10/320,045
Granted
Dec 27, 2005
Kind
B2
Abstract

A method of cleaning a metered dose spray device, and a cleaning composition for such cleaning, prevent the device from becoming clogged with medication. The method includes removing the aerosol can containing the medication from the actuator, placing an aerosol can containing a cleaning composition in the actuator, and dispensing the cleaning solution through the actuator. The residual medication is thereby removed from the actuator. A sufficiently small quantity of cleaning composition remains in the actuator so that the cleaning composition itself will not clog the actuator. Additionally, the cleaning composition is non-toxic, so that residual cleaning composition remaining in the actuator will not harm the user when a subsequent dose of medication is dispensed.

Claims (9)

1. A method of cleaning an actuator of an aerosol metered dose dispenser containing a pharmaceutical product, comprising:

replacing the canister containing the pharmaceutical product with a canister containing a cleaning composition; and

discharging the cleaning canister at least one time after discharge of the pharmaceutical product so that the pharmaceutical product residue present in the actuator is substantially removed by the discharge of the cleaning composition therethrough.

2. The method of claim 1 , wherein said cleaning composition is comprised of a propellant and silicone.

3. The method of claim 2 , wherein said propellant is selected from the group consisting of tetrafluoroethane, heptafluoroethane, dimethylfluoropropane,, tetrafluoropropane, butane, isobutane, diethyl ether, hydrogen-containing chlorofluorocarbons, hydrogen-containing chlorofluorocarbons, hydrogen-containing fluorocarbons, and diethyl ether.

4. The method of claim 2 , wherein the propellant is present in a concentration of about 90 to 99 wt./wt. % of the total cleaning composition and the silicone is present in a concentration of about 1 to 10 wt./wt. % of the total cleaning composition.

5. The method of claim 2 , further comprising an organic solvent.

6. The method of claim 5 , wherein the organic solvent is selected from the group consisting of alcohol solutions and ethanol an alcohol solution.

7. The method of claim 6 , wherein the alcohol solution is ethanol.

Assignments (8)
SECURITY AGREEMENT Recorded Apr 4, 2008
From: GENEREX PHARMACEUTICALS INC.
To: CRANSHIRE CAPITAL, L.P.
Reel/Frame 020753/0592 →
SECURITY AGREEMENT Recorded Apr 4, 2008
From: GENEREX PHARMACEUTICALS INC.
To: SMITHFIELD FIDUCIARY LLC
Reel/Frame 020753/0662 →
SECURITY AGREEMENT Recorded Apr 4, 2008
From: GENEREX PHARMACEUTICALS INC.
To: IROQUOIS CAPITAL OPPORTUNITY FUND, LP
Reel/Frame 020753/0704 →
SECURITY AGREEMENT Recorded Apr 4, 2008
From: GENEREX PHARMACEUTICALS INC.
To: PORTSIDE GROWTH AND OPPORTUNITY FUND
Reel/Frame 020753/0751 →
SECURITY AGREEMENT Recorded Apr 4, 2008
From: GENEREX PHARMACEUTICALS INC.
To: ROCKMORE INVESTMENT MASTER FUND LTD.
Reel/Frame 020753/0822 →
SECURITY AGREEMENT Recorded Apr 4, 2008
From: GENEREX PHARMACEUTICALS INC.
To: IROQUOIS MASTER FUND LTD.
Reel/Frame 020794/0416 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2004
From: GENEREX BIOTECHNOLOGY CORPORATION
To: GENEREX PHARMACEUTICALS INCORPORATED
Reel/Frame 015096/0139 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2003
From: MODI, PANKAJ
To: GENEREX BIOTECHNOLOGY CORPORATION
Reel/Frame 014666/0679 →
Continuity (1)
Related Publication 20040116318A1 · Jun 17, 2004